Impact of Sunitinib on Human Thyroid Cancer Cells

  • Jirka Grossea, Elisabeth Warnkeb, +5 authors Daniela Grimmb
  • Published 2013


Background/Aims: Thyroid cancer accounts for about 1% of all cancer cases. Multikinase inhibitors like sunitinib (S) have a promising potential in thyroid cancer therapy. Therefore, the principal aim of this study was to investigate the impact of sunitinib on the secretion of cytokines of follicular thyroid cancer cells. Method: The effects of irradiation… (More)


4 Figures and Tables

Slides referencing similar topics